Celiac disease: diagnosis, autoimmune mechanisms and treatment

References

• Dicke WK, Weijers HA, Van De Kamer JH. Coeliac disease. II. The presence in wheat of a factor having a deleterious effect in cases of coeliac disease. Acta Paediatr.42(1), 34–42 (1953).
   PubMedGoogle Scholar
• Johnston SD, Watson RG, McMillan SA, Sloan J, Love AH. Prevalence of coeliac disease in Northern Ireland. Lancet350(9088), 1370 (1997).
   PubMed Web of Science ®Google Scholar
• Fasano A BI, Gerarduzzi T, Not T et al. Prevalence of celiac disease in at-risk and not-at-risk groups in the United States: a large multicenter study. Arch. Intern. Med.163(3), 259–292 (2003).
   Google Scholar
• Not T, Horvath K, Hill ID et al. Celiac disease risk in the USA: high prevalence of antiendomysium antibodies in healthy blood donors. Scand. J. Gastroenterol.33(5), 494–498 (1998).
   PubMed Web of Science ®Google Scholar
• Weile I, Grodzinsky E, Skogh T, Jordal R, Cavell B, Krasilnikoff PA. High prevalence rates of adult silent coeliac disease, as seen in Sweden, must be expected in Denmark. Apmis109(11), 745–750 (2001).
   PubMed Web of Science ®Google Scholar
• Catassi C, Fabiani E. The spectrum of coeliac disease in children. Baillieres Clin. Gastroenterol.11(3), 485–507 (1997).
   PubMedGoogle Scholar
• Rampertab SD, Pooran N, Brar P, Singh P, Green PH. Trends in the presentation of celiac disease. Am. J. Med.119(4), 355 e359–e314 (2006).
   Google Scholar
• Greco L, Romino R, Coto I et al. The first large population based twin study of coeliac disease. Gut50(5), 624–628 (2002).
   PubMed Web of Science ®Google Scholar
• Green PHR, Stavropoulos SN, Panagi SG et al. Characteristics of adult celiac disease in the USA: results of a national survey. Am. J. Gastroenterol.96(1), 126–131 (2001).
   PubMed Web of Science ®Google Scholar
• Collin P, Reunala T, Rasmussen M et al. High incidence and prevalence of adult coeliac disease. Augmented diagnostic approach. Scand. J. Gastroenterol.32(11), 1129–1133 (1997).
   PubMed Web of Science ®Google Scholar
• Abuzakouk M, Barnes L, O’Gorman N et al. Dermatitis herpetiformis: no evidence of bone disease despite evidence of enteropathy. Dig. Dis. Sci.52(3), 659–664 (2007).
   PubMed Web of Science ®Google Scholar
• Sardy M, Karpati S, Merkl B, Paulsson M, Smyth N. Epidermal transglutaminase (TGase 3) is the autoantigen of dermatitis herpetiformis. J. Exp. Med.195(6), 747–757 (2002).
   PubMed Web of Science ®Google Scholar
• Balas A, Vicario JL, Zambrano A, Acuna D, Garcia-Novo D. Absolute linkage of celiac disease and dermatitis herpetiformis to HLA-DQ. Tissue Antigens50(1), 52–56 (1997).
   PubMedGoogle Scholar
• Garioch JJ, Lewis HM, Sargent SA, Leonard JN, Fry L. 25 years’ experience of a gluten-free diet in the treatment of dermatitis herpetiformis. Br. J. Dermatol.131(4), 541–545 (1994).
   PubMed Web of Science ®Google Scholar
• Tursi A, Giorgetti G, Brandimarte G, Rubino E, Lombardi D, Gasbarrini G. Prevalence and clinical presentation of subclinical/silent celiac disease in adults: an analysis on a 12-year observation. Hepatogastroenterology48(38), 462–464 (2001).
   PubMedGoogle Scholar
• Farrell RJ, Kelly CP. Celiac sprue. N. Engl. J. Med.346(3), 180–188 (2002).
   PubMed Web of Science ®Google Scholar
• Sategna-Guidetti C, Grosso SB, Grosso S et al. The effects of 1-year gluten withdrawal on bone mass, bone metabolism and nutritional status in newly-diagnosed adult coeliac disease patients. Aliment Pharmacol. Ther.14(1), 35–43 (2000).
   PubMed Web of Science ®Google Scholar
• Kagnoff M. Overview and pathogenesis of celiac disease. Gastroenterology128(4 Suppl. 1), S10–S18 (2005).
   Google Scholar
• Ferguson A, MacDonald TT, McClure JP, Holden RJ. Cell-mediated immunity to gliadin within the small-intestinal mucosa in coeliac disease. Lancet1(7912), 895–897 (1975).
   PubMed Web of Science ®Google Scholar
• Marsh MN. Gluten, major histocompatibility complex, and the small intestine. A molecular and immunobiologic approach to the spectrum of gluten sensitivity (‘celiac sprue’). Gastroenterology102(1), 330–354 (1992).
   PubMed Web of Science ®Google Scholar
• Green PH JB. Coeliac disease. Lancet362(9381), 383–391 (2003).
   PubMed Web of Science ®Google Scholar
• Rescigno M, Urbano M, Valzasina B et al. Dendritic cells express tight junction proteins and penetrate gut epithelial monolayers to sample bacteria. Nat. Immunol.2(4), 361–367 (2001).
   PubMed Web of Science ®Google Scholar
• Stepniak D, Koning F. Celiac disease – sandwiched between innate and adaptive immunity. Hum. Immunol.67(6), 460–468 (2006).
   PubMed Web of Science ®Google Scholar
• Stene LC, Honeyman MC, Hoffenberg EJ et al. Rotavirus infection frequency and risk of celiac disease autoimmunity in early childhood: a longitudinal study. Am. J. Gastroenterol.101(10), 2333–2340 (2006).
   PubMed Web of Science ®Google Scholar
• Zanoni G, Navone R, Lunardi C et al. In celiac disease, a subset of autoantibodies against transglutaminase binds Toll-like receptor 4 and induces activation of monocytes. PLoS Med.3(9), e358 (2006).
   PubMed Web of Science ®Google Scholar
• Kagnoff M. Celiac disease: pathogenesis of a model immunogenetic disease. J. Clin. Invest.117(1), 41–49 (2007).
   PubMed Web of Science ®Google Scholar
• Molberg O, McAdam SN, Korner R et al. Tissue transglutaminase selectively modifies gliadin peptides that are recognized by gut-derived T cells in celiac disease. Nat. Med.4(6), 713–717 (1998).
   PubMed Web of Science ®Google Scholar
• van de Wal Y, Kooy Y, van Veelen P et al. Selective deamidation by tissue transglutaminase strongly enhances gliadin-specific T cell reactivity. J. Immunol.161(4), 1585–1588 (1998).
   PubMed Web of Science ®Google Scholar
• Dieterich W, Ehnis T, Bauer M et al. Identification of tissue transglutaminase as the autoantigen of celiac disease. Nat. Med.3(7), 797–801 (1997).
   PubMed Web of Science ®Google Scholar
• van Belzen MJ, Mulder CJ, Zhernakova A, Pearson PL, Houwen RH, Wijmenga C. CTLA4 +49 A/G and CT60 polymorphisms in Dutch coeliac disease patients. Eur. J. Hum. Genet.12(9), 782–785 (2004).
   PubMed Web of Science ®Google Scholar
• Mora B, Bonamico M, Indovina P et al. CTLA-4 +49 A/G dimorphism in Italian patients with celiac disease. Hum. Immunol.64(2), 297–301 (2003).
   PubMed Web of Science ®Google Scholar
• King AL, Moodie SJ, Fraser JS et al. CTLA-4/CD28 gene region is associated with genetic susceptibility to coeliac disease in UK families. J. Med. Genet.39(1), 51–54 (2002).
   PubMed Web of Science ®Google Scholar
• van Heel DA, Franke L, Hunt KA et al. A genome-wide association study for celiac disease identifies risk variants in the region harboring IL2 and IL21. Nat. Genet.39(7), 827–829 (2007).
   PubMed Web of Science ®Google Scholar
• Cirillo G, Di Domenico MR, Corsi I et al. Do MYO9B genetic variants predispose to coeliac disease? An association study in a cohort of South Italian children. Dig. Liver Dis.39(3), 228–231 (2007).
   PubMedGoogle Scholar
• Nunez C, Marquez A, Varade J et al. No evidence of association of the MYO9B polymorphisms with celiac disease in the Spanish population. Tissue Antigens68(6), 489–492 (2006).
   PubMed Web of Science ®Google Scholar
• Monsuur AJ, de Bakker PI, Alizadeh BZ et al. Myosin IXB variant increases the risk of celiac disease and points toward a primary intestinal barrier defect. Nat. Genet.37(12), 1341–1344 (2005).
   PubMed Web of Science ®Google Scholar
• Kagnoff M. HLA genes in coeliac disease. In: Coeliac Disease. Auricchio A, Maiuri L, Troncone R (Eds). JCG Editions, Naples, Italy 5–14 (2000).
   Google Scholar
• Howell MD, Austin RK, Kelleher D, Nepom GT, Kagnoff MF. An HLA-D region restriction fragment length polymorphism associated with celiac disease. J. Exp. Med.164(1), 333–338 (1986).
   PubMedGoogle Scholar
• Lundin KE, Scott H, Fausa O, Thorsby E, Sollid LM. T cells from the small intestinal mucosa of a DR4, DQ7/DR4, DQ8 celiac disease patient preferentially recognize gliadin when presented by DQ8. Hum. Immunol.41(4), 285–291 (1994).
   PubMed Web of Science ®Google Scholar
• Mazzarella G, Maglio M, Paparo F et al. An immunodominant DQ8 restricted gliadin peptide activates small intestinal immune response in in vitro cultured mucosa from HLA-DQ8 positive but not HLA-DQ8 negative coeliac patients. Gut52(1), 57–62 (2003).
   PubMed Web of Science ®Google Scholar
• Nilsen EM, Jahnsen FL, Lundin KE et al. Gluten induces an intestinal cytokine response strongly dominated by interferon γ in patients with celiac disease. Gastroenterology115(3), 551–563 (1998).
   PubMed Web of Science ®Google Scholar
• Maiuri L, Ciacci C, Ricciardelli I et al. Association between innate response to gliadin and activation of pathogenic T cells in coeliac disease. Lancet362(9377), 30–37 (2003).
   PubMed Web of Science ®Google Scholar
• Hue S, Mention JJ, Monteiro RC et al. A direct role for NKG2D/MICA interaction in villous atrophy during celiac disease. Immunity21(3), 367–377 (2004).
   PubMed Web of Science ®Google Scholar
• Sollid LM, Molberg O, McAdam S, Lundin KE. Autoantibodies in coeliac disease: tissue transglutaminase – guilt by association? Gut41(6), 851–852 (1997).
   PubMed Web of Science ®Google Scholar
• Ventura A, Magazzu G, Greco L. Duration of exposure to gluten and risk for autoimmune disorders in patients with celiac disease. SIGEP Study Group for Autoimmune Disorders in Celiac Disease. Gastroenterology117(2), 297–303 (1999).
   PubMed Web of Science ®Google Scholar
• Cuoco L, Certo M, Jorizzo RA et al. Prevalence and early diagnosis of coeliac disease in autoimmune thyroid disorders. Ital. J. Gastroenterol. Hepatol.31(4), 283–287 (1999).
   PubMedGoogle Scholar
• Collin P, Salmi J, Hallstrom O, Reunala T, Pasternack A. Autoimmune thyroid disorders and coeliac disease. Eur. J. Endocrinol.130(2), 137–140 (1994).
   PubMedGoogle Scholar
• McDermott MT, McNally PR. A possible association between Graves’ disease and gluten-sensitive enteropathy. Thyroid9(12), 1281 (1999).
   PubMedGoogle Scholar
• Valentino R, Savastano S, Tommaselli AP et al. Prevalence of coeliac disease in patients with thyroid autoimmunity. Horm. Res.51(3), 124–127 (1999).
   PubMed Web of Science ®Google Scholar
• Badenhoop K, Walfish PG, Rau H et al. Susceptibility and resistance alleles of human leukocyte antigen (HLA) DQA1 and HLA DQB1 are shared in endocrine autoimmune disease. J. Clin. Endocrinol. Metab.80(7), 2112–2117 (1995).
   PubMed Web of Science ®Google Scholar
• Kent L, McBride R, McConnell R, Neugut AI, Bhagat G, Green PH. Increased risk of papillary thyroid cancer in celiac disease. Dig. Dis. Sci.51(10), 1875–1877 (2006).
   PubMedGoogle Scholar
• Bao F, Yu L, Babu S et al. One third of HLA DQ2 homozygous patients with Type 1 diabetes express celiac disease-associated transglutaminase autoantibodies. J. Autoimmun.13(1), 143–148 (1999).
   PubMed Web of Science ®Google Scholar
• Hummel M, Bonifacio E, Stern M, Dittler J, Schimmel A, Ziegler AG. Development of celiac disease-associated antibodies in offspring of parents with Type I diabetes. Diabetologia43(8), 1005–1011 (2000).
   PubMed Web of Science ®Google Scholar
• Seissler J, Schott M, Boms S et al. Autoantibodies to human tissue transgutaminase identify silent coeliac disease in Type I diabetes. Diabetologia42(12), 1440–1441 (1999).
   PubMedGoogle Scholar
• Volta U, De Franceschi L, Lari F, Molinaro N, Zoli M, Bianchi FB. Coeliac disease hidden by cryptogenic hypertransaminasaemia. Lancet352(9121), 26–29 (1998).
   PubMed Web of Science ®Google Scholar
• Kingham JG, Parker DR. The association between primary biliary cirrhosis and coeliac disease: a study of relative prevalences. Gut42(1), 120–122 (1998).
   PubMed Web of Science ®Google Scholar
• Sorensen HT, Thulstrup AM, Blomqvist P, Norgaard B, Fonager K, Ekbom A. Risk of primary biliary liver cirrhosis in patients with coeliac disease: Danish and Swedish cohort data. Gut44(5), 736–738 (1999).
   PubMed Web of Science ®Google Scholar
• Hu WT, Murray JA, Greenaway MC, Parisi JE, Josephs KA. Cognitive impairment and celiac disease. Arch. Neurol.63(10), 1440–1446 (2006).
   PubMedGoogle Scholar
• Zelnik N, Pacht A, Obeid R, Lerner A. Range of neurologic disorders in patients with celiac disease. Pediatrics113(6), 1672–1676 (2004).
   PubMed Web of Science ®Google Scholar
• Corrao G, Corazza GR, Bagnardi V et al. Mortality in patients with coeliac disease and their relatives: a cohort study. Lancet358(9279), 356–361 (2001).
   PubMed Web of Science ®Google Scholar
• Cottone M, Termini A, Oliva L et al. Mortality and causes of death in celiac disease in a Mediterranean area. Dig. Dis. Sci.44(12), 2538–2541 (1999).
   PubMed Web of Science ®Google Scholar
• Logan RF, Rifkind EA, Turner ID, Ferguson A. Mortality in celiac disease. Gastroenterology97(2), 265–271 (1989).
   PubMed Web of Science ®Google Scholar
• Holmes GK, Prior P, Lane MR, Pope D, Allan RN. Malignancy in coeliac disease – effect of a gluten free diet. Gut30(3), 333–338 (1989).
   PubMed Web of Science ®Google Scholar
• West J, Logan RF, Smith CJ, Hubbard RB, Card TR. Malignancy and mortality in people with coeliac disease: population based cohort study. Br. Med. J.329(7468), 716–719 (2004).
   PubMed Web of Science ®Google Scholar
• Green PH, Fleischauer AT, Bhagat G, Goyal R, Jabri B, Neugut AI. Risk of malignancy in patients with celiac disease. Am. J. Med.115(3), 191–195 (2003).
   PubMed Web of Science ®Google Scholar
• Fasano A, Catassi C. Current approaches to diagnosis and treatment of celiac disease: an evolving spectrum. Gastroenterology120(3), 636–651 (2001).
   PubMed Web of Science ®Google Scholar
• Hill ID, Dirks MH, Liptak GS et al. Guideline for the diagnosis and treatment of celiac disease in children: recommendations of the North American Society for Pediatric Gastroenterology Hepatology and Nutrition. J. Pediatr. Gastroenterol. Nutr.40(1), 1–19 (2005).
   PubMed Web of Science ®Google Scholar
• Meini A, Pillan NM, Villanacci V, Monafo V, Ugazio AG, Plebani A. Prevalence and diagnosis of celiac disease in IgA-deficient children. Ann. Allergy Asthma Immunol.77(4), 333–336 (1996).
   PubMedGoogle Scholar
• Rubin CE, Brandborg LL, Phelps PC, Taylor HC Jr. Studies of celiac disease. I. The apparent identical and specific nature of the duodenal and proximal jejunal lesion in celiac disease and idiopathic sprue. Gastroenterology38, 28–49 (1960).
   PubMed Web of Science ®Google Scholar
• Oberhuber G, Granditsch G, Vogelsang H. The histopathology of coeliac disease: time for a standardized report scheme for pathologists. Eur. J. Gastroenterol. Hepatol.11(10), 1185–1194 (1999).
   PubMed Web of Science ®Google Scholar
• Prince HE. Evaluation of the INOVA diagnostics enzyme-linked immunosorbent assay kits for measuring serum immunoglobulin G (IgG) and IgA to deamidated gliadin peptides. Clin. Vaccine Immunol.13(1), 150–151 (2006).
   PubMedGoogle Scholar
• Barker CC, Mitton C, Jevon G, Mock T. Can tissue transglutaminase antibody titers replace small-bowel biopsy to diagnose celiac disease in select pediatric populations? Pediatrics115(5), 1341–1346 (2005).
   PubMed Web of Science ®Google Scholar
• Ciclitira PJ, King AL, Fraser JS. AGA technical review on celiac sprue. American Gastroenterological Association. Gastroenterology120(6), 1526–1540 (2001).
   PubMedGoogle Scholar
• Murray JA, Van Dyke C, Plevak MF, Dierkhising RA, Zinsmeister AR, Melton LJ 3rd. Trends in the identification and clinical features of celiac disease in a North American community, 1950–2001. Clin. Gastroenterol. Hepatol.1(1), 19–27 (2003).
   PubMed Web of Science ®Google Scholar
• Lo W, Sano K, Lebwohl B, Diamond B, Green PH. Changing presentation of adult celiac disease. Dig. Dis. Sci.48(2), 395–398 (2003).
   PubMed Web of Science ®Google Scholar
• Leffler DA, Dennis M, Hyett B, Kelly E, Schuppan D, Kelly CP. Etiologies and predictors of diagnosis in nonresponsive celiac disease. Clin. Gastroenterol. Hepatol.5(4), 445–450 (2007).
   PubMed Web of Science ®Google Scholar
• Abdulkarim AS, Burgart LJ, See J, Murray JA. Etiology of nonresponsive celiac disease: results of a systematic approach. Am. J. Gastroenterol.97(8), 2016–2021 (2002).
   PubMed Web of Science ®Google Scholar
• National Institutes of Health Consensus Development conference statement on celiac disease. Gastroenterology128(4 Suppl. 1), S1–S9 (2005).
   PubMedGoogle Scholar
• Leffler D, Kelly CP. What the last few years have taught us. In: Advances in Digestive Disease. AGA Institute Press, MD, USA (2007)
   Google Scholar
• Hogberg L, Laurin P, Falth-Magnusson K et al. Oats to children with newly diagnosed coeliac disease: a randomised double blind study. Gut53(5), 649–654 (2004).
   PubMed Web of Science ®Google Scholar
• Srinivasan U, Jones E, Carolan J, Feighery C. Immunohistochemical analysis of coeliac mucosa following ingestion of oats. Clin. Exp. Immunol.144(2), 197–203 (2006).
   PubMed Web of Science ®Google Scholar
• Lundin KE, Nilsen EM, Scott HG et al. Oats induced villous atrophy in coeliac disease. Gut52(11), 1649–1652 (2003).
   PubMed Web of Science ®Google Scholar
• Bernstein CN, Leslie WD, Leboff MS. AGA technical review on osteoporosis in gastrointestinal diseases. Gastroenterology124(3), 795–841 (2003).
   PubMed Web of Science ®Google Scholar
• Pink IJ, Creamer B. Response to a gluten-free diet of patients with the coeliac syndrome. Lancet1(7485), 300–304 (1967).
   PubMedGoogle Scholar
• Khosla C, Gray GM, Sollid LM. Putative efficacy and dosage of prolyl endopeptidase for digesting and detoxifying gliadin peptides. Gastroenterology129(4), 1362–1363; author reply 1363 (2005).
   PubMed Web of Science ®Google Scholar
• Stepniak D, Spaenij-Dekking L, Mitea C et al. Highly efficient gluten degradation with a newly identified prolyl endoprotease: implications for celiac disease. Am. J. Physiol. Gastrointest. Liver Physiol.291(4), G621–G629 (2006).
   PubMed Web of Science ®Google Scholar
• Shan L, Molberg O, Parrot I et al. Structural basis for gluten intolerance in celiac sprue. Science297(5590), 2275–2279 (2002).
   PubMed Web of Science ®Google Scholar
• Edens L, Dekker P, van der Hoeven R, Deen F, de Roos A, Floris R. Extracellular prolyl endoprotease from Aspergillus niger and its use in the debittering of protein hydrolysates. J. Agric. Food Chem.53(20), 7950–7957 (2005).
   PubMed Web of Science ®Google Scholar
• Vader LW, Stepniak DT, Bunnik EM et al. Characterization of cereal toxicity for celiac disease patients based on protein homology in grains. Gastroenterology125(4), 1105–1113 (2003).
   PubMed Web of Science ®Google Scholar
• Ivarsson A, Hernell O, Stenlund H, Persson LA. Breast-feeding protects against celiac disease. Am. J. Clin. Nutr.75(5), 914–921 (2002).
   PubMed Web of Science ®Google Scholar
• Peters U, Schneeweiss S, Trautwein EA, Erbersdobler HF. A case–control study of the effect of infant feeding on celiac disease. Ann. Nutr. Metab.45(4), 135–142 (2001).
   PubMed Web of Science ®Google Scholar
• Maki M, Kallonen K, Lahdeaho ML, Visakorpi JK. Changing pattern of childhood coeliac disease in Finland. Acta Paediatr. Scand.77(3), 408–412 (1988).
   PubMed Web of Science ®Google Scholar
• Ascher H, Krantz I, Rydberg L, Nordin P, Kristiansson B. Influence of infant feeding and gluten intake on coeliac disease. Arch. Dis. Child76(2), 113–117 (1997).
   PubMed Web of Science ®Google Scholar
• Norris JM, Barriga K, Hoffenberg EJ et al. Risk of celiac disease autoimmunity and timing of gluten introduction in the diet of infants at increased risk of disease. JAMA293(19), 2343–2351 (2005).
   PubMed Web of Science ®Google Scholar
• Gartner LM, Morton J, Lawrence RA et al. Breastfeeding and the use of human milk. Pediatrics115(2), 496–506 (2005).
   PubMed Web of Science ®Google Scholar
• Goerres MS, Meijer JW, Wahab PJ et al. Azathioprine and prednisone combination therapy in refractory coeliac disease. Aliment Pharmacol. Ther.18(5), 487–494 (2003).
   PubMed Web of Science ®Google Scholar